These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15307590)

  • 21. Ulcerative post-kala azar mucosal leishmaniasis masquerading as a carcinoma--a case report.
    Toran KC; Sah SP; Joshi A; Rani S
    Indian J Pathol Microbiol; 2003 Jul; 46(3):487-9. PubMed ID: 15025319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh.
    Sultana A; Zakaria SM; Bhuiyan SI; Habib A; Dey SK; Rahman M; Basher A
    Mymensingh Med J; 2012 Jul; 21(3):529-32. PubMed ID: 22828555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing Knowledge, Attitudes, and Preventive Practices Related to Kala-A: A Study of Rural Madhepura, Bihar, India.
    Govil D; Sahoo H; Pedgaonkar SP; Chandra Das K; Lhungdim H
    Am J Trop Med Hyg; 2018 Mar; 98(3):857-863. PubMed ID: 29280426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological study of clinically undiagnosed cases of kala-azar with special reference to grading of parasites.
    Mukherjee C; Mitra PK; Dasgupta A; Ghosh RN
    J Indian Med Assoc; 1995 Mar; 93(3):87-9. PubMed ID: 8522820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is elimination of kala-azar feasible by 2017?
    Thakur CP
    Indian J Med Res; 2016 Dec; 144(6):799-802. PubMed ID: 28474615
    [No Abstract]   [Full Text] [Related]  

  • 28. Atypical disseminated leishmaniasis similar to post-kala-azar dermal leishmaniasis in a Brazilian AIDS patient infected with Leishmania (Leishmania) infantum chagasi: a case report.
    Carnaúba D; Konishi CT; Petri V; Martinez IC; Shimizu L; Pereira-Chioccola VL
    Int J Infect Dis; 2009 Nov; 13(6):e504-7. PubMed ID: 19447660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of co-infection of Leptomonas in visceral leishmaniasis in India.
    Selvapandiyan A; Ahuja K; Puri N; Krishnan A
    Parasitology; 2015 Dec; 142(14):1657-62. PubMed ID: 26492813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
    Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral leishmaniasis in the New World & Africa.
    Berman J
    Indian J Med Res; 2006 Mar; 123(3):289-94. PubMed ID: 16778311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Images in clinical medicine. Kala-azar.
    Pantsari MW; Coleman TA
    N Engl J Med; 2003 Oct; 349(14):e13. PubMed ID: 14523156
    [No Abstract]   [Full Text] [Related]  

  • 35. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
    Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
    Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post kala-azar ocular leishmaniasis.
    el Hassan AM; Khalil EA; el Sheikh EA; Zijlstra EE; Osman A; Ibrahim ME
    Trans R Soc Trop Med Hyg; 1998; 92(2):177-9. PubMed ID: 9764325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.
    Salotra P; Sreenivas G; Pogue GP; Lee N; Nakhasi HL; Ramesh V; Negi NS
    J Clin Microbiol; 2001 Mar; 39(3):849-54. PubMed ID: 11230394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leishmania donovani donovani and Leishmania donovani chagasi as antigens in a direct agglutination assay for the diagnosis of kala-azar.
    Andrade CR; Nascimento AE; Moura PM; Andrade PP
    Braz J Med Biol Res; 1989; 22(5):611-5. PubMed ID: 2620171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and characterization of Leishmania in tissues of patients with post kala-azar dermal leishmaniasis using a specific monoclonal antibody.
    Ismail A; Kharazmi A; Permin H; el Hassan AM
    Trans R Soc Trop Med Hyg; 1997; 91(3):283-5. PubMed ID: 9231195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
    Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N
    J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.